PURPOSE: Magnetic resonance imaging (MRI) is a promising approach for non-invasive monitoring after liver cell transplantation. We compared in vitro labeling of human liver cells with nano-sized (SPIO) and micron-sized iron oxide particles (MPIO). PROCEDURES: The cellular iron load was quantified and phantom studies were performed using 3.0-T MRI. Transferrin receptor and ferritin gene expression, reactive oxygen species (ROS) formation, transaminase leakage, and urea synthesis were investigated over 6 days. RESULTS: Incubation with MPIO produced stronger signal extinctions in MRI at similar iron loads within shorter labeling time. MPIO had no negative effects on the cellular iron homeostasis or cell performance, whereas SPIO caused temporary ROS formation and non-physiologic activation of the iron metabolic pathway. CONCLUSIONS: Our findings suggest that MPIO are suited for clinical translation of strategies for cellular imaging with MRI. Attention should be paid to iron release and oxidative stress caused by biodegradable contrast agents.
PURPOSE: Magnetic resonance imaging (MRI) is a promising approach for non-invasive monitoring after liver cell transplantation. We compared in vitro labeling of human liver cells with nano-sized (SPIO) and micron-sized iron oxide particles (MPIO). PROCEDURES: The cellular iron load was quantified and phantom studies were performed using 3.0-T MRI. Transferrin receptor and ferritin gene expression, reactive oxygen species (ROS) formation, transaminase leakage, and urea synthesis were investigated over 6 days. RESULTS: Incubation with MPIO produced stronger signal extinctions in MRI at similar iron loads within shorter labeling time. MPIO had no negative effects on the cellular iron homeostasis or cell performance, whereas SPIO caused temporary ROS formation and non-physiologic activation of the iron metabolic pathway. CONCLUSIONS: Our findings suggest that MPIO are suited for clinical translation of strategies for cellular imaging with MRI. Attention should be paid to iron release and oxidative stress caused by biodegradable contrast agents.
Authors: Kathleen A Hinds; Jonathan M Hill; Erik M Shapiro; Mikko O Laukkanen; Alfonso C Silva; Christian A Combs; Timothy R Varney; Robert S Balaban; Alan P Koretsky; Cynthia E Dunbar Journal: Blood Date: 2003-04-03 Impact factor: 22.113
Authors: Annelies Crabbe; Caroline Vandeputte; Tom Dresselaers; Angel Ayuso Sacido; Jose Manuel Garcia Verdugo; Jeroen Eyckmans; Frank P Luyten; Koen Van Laere; Catherine M Verfaillie; Uwe Himmelreich Journal: Cell Transplant Date: 2010-03-26 Impact factor: 4.064
Authors: Ali S Arbab; Lindsey A Bashaw; Bradley R Miller; Elaine K Jordan; Jeff W M Bulte; Joseph A Frank Journal: Transplantation Date: 2003-10-15 Impact factor: 4.939
Authors: Nathanael Raschzok; Nils Billecke; Nora N Kammer; Mehmet H Morgul; Michaela K Adonopoulou; Igor M Sauer; Stefan Florek; Helmut Becker-Ross; Mao Dong Huang Journal: Tissue Eng Part C Methods Date: 2009-12 Impact factor: 3.056
Authors: Martin Rodriguez-Porcel; Marvin W Kronenberg; Timothy D Henry; Jay H Traverse; Carl J Pepine; Stephen G Ellis; James T Willerson; Lemuel A Moyé; Robert D Simari Journal: JACC Cardiovasc Imaging Date: 2012-05
Authors: Dwayne R Roach; Wesley M Garrett; Glenn Welch; Thomas J Caperna; Neil C Talbot; Erik M Shapiro Journal: PLoS One Date: 2015-04-09 Impact factor: 3.240
Authors: Maximilian Y Emmert; Benedikt Weber; Petra Wolint; Thomas Frauenfelder; Steffen M Zeisberger; Luc Behr; Sebastien Sammut; Jacques Scherman; Chad E Brokopp; Ruth Schwartländer; Viola Vogel; Peter Vogt; Jürg Grünenfelder; Hatem Alkadhi; Volkmar Falk; Andreas Boss; Simon P Hoerstrup Journal: PLoS One Date: 2013-03-22 Impact factor: 3.240